Show
Sort by
-
Considerations on the design of lipid-based mRNA vaccines against cancer
-
- Journal Article
- A1
- open access
Exciting times for lipid nanoparticles : how Canadian discoveries are enabling gene therapies
-
- Journal Article
- A1
- open access
The dawn of mRNA vaccines : the COVID-19 case
-
- Journal Article
- A1
- open access
Three decades of messenger RNA vaccine development
-
Co-delivery of nucleoside-modified mRNA and TLR agonists for cancer immunotherapy : restoring the immunogenicity of immunosilent mRNA